The UK-based drug major AstraZeneca has filed one more patent lawsuit against Gujarat-based Torrent Pharmaceuticals and its US subsidiary, for alleged move to manufacture and sell the generic version of its extended release anti-psychotic drug, Seroquel XR prior to the expiry of its patent.
AstraZenca, a UK based drug major company which has just entered as manufacturing partnership with Torrent pharma in March 2010.
AstraZeneca has filed a complaint against Torrent Pharma in the District Court of New Jersey, US, following the a Para IV filing to produce and market the quetiapine fumarate extended release drug, the generic form of AstraZeneca's Seroquel XR, used to treat schizophrenia and bipolar disorder, which is having sales value of $913 million.
Full article can be view at http://www.pharmabiz.com/article/detnews.asp?articleid=57084§ionid=
No comments:
Post a Comment